# Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD) on Frailty, Cognition, and Quality of Life. A Gender-sensitive Approach Towards a Comprehensive and Equitable Perspective.

> **NCT07652892** · — · RECRUITING · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau** · enrollment: 140 (estimated)

## Conditions studied

- Steatosis of Liver

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07652892
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-26
- **Primary completion:** 2027-02-25
- **Final completion:** 2028-05-25
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07652892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07652892, "Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD) on Frailty, Cognition, and Quality of Life. A Gender-sensitive Approach Towards a Comprehensive and Equitable Perspective.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07652892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*